InvestorsHub Logo

maytepper

11/20/14 11:14 AM

#84296 RE: $heff #84261

$SGYP Cantor Raises Synergy Pharmaceuticals Price Target Following Positive Phase 2 OIC Data For SP-333 http://www.smarteranalyst.com/2014/11/20/cantor-raises-synergy-pharmaceuticals-positive-phase-2-oic-data-for-sp-333/

mathew633

01/29/15 10:25 AM

#85610 RE: $heff #84261

$heff

02/02/15 9:13 AM

#85688 RE: $heff #84261

$SGYP.. Completes Enrollment for the Second Pivotal Ph.3 Trial of Plecanatide. http://t.co/G021bTGVUu Topline data will be in Q3. Key catalyst to watch for!